Multiple system atrophy. Clinical aspects, pathophysiology, and treatment.
Progressive autonomic failure is a clinical syndrome of autonomic dysfunction that may occur in isolation as in idiopathic orthostatic hypotension (IOH) or in association with a central neurologic disorder, multiple system atrophy (MSA). MSA and IOH can be distinguished on the basis of biochemical and pharmacologic tests. Plasma norepinephrine levels are low in IOH and normal in MSA; neither group increases the plasma norepinephrine level adequately in response to postural change. Both MSA and IOH manifest an exaggerated pressor response to administered norepinephrine. However, only patients with IOH have true adrenergic receptor supersensitivity. The autonomic dysfunction in IOH primarily involves the peripheral autonomic neurons whereas the defect in MSA is the failure to activate appropriately an intact distal sympathetic nervous system. Neuropathologic studies reveal a multisystem degeneration in MSA; the few postmortem examinations of the central nervous system in IOH reveal lesions confined to the intermediolateral columns of the spinal cord. Orthostatic hypotension may be treated with a number of medications although supine hypertension limits the usefulness of these drugs. Further development and testing of a sympathetic neural prosthesis may help to resolve this therapeutic dilemma. Only the parkinsonian features in MSA respond to treatment with anticholinergic drugs.
D001146:Arrhythmia, Sinus; D001341:Autonomic Nervous System / Q000473:pathology / Q000503:physiopathology; D001342:Autonomic Nervous System Diseases / Q000175:diagnosis*; D002490:Central Nervous System / Q000473:pathology; D003080:Cold Temperature; D006801:Humans; D009638:Norepinephrine / Q000652:urine; D012021:Reflex, Abnormal; D012791:Shy-Drager Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D014636:Valsalva Maneuver
D009638:Norepinephrine